Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
This study has been completed.
Information provided by (Responsible Party):
First received: October 1, 2009
Last updated: March 22, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2010|
|Primary Completion Date:||April 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||July 2, 2010|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, Li P, Walravens K, Gillard P, Roman F. Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults. Hum Vaccin Immunother. 2012 Feb;8(2):260-6. doi: 10.4161/hv.18469. Epub 2012 Feb 1.